These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 26354229
1. Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis. Tang YN, Ding WQ, Guo XJ, Yuan XW, Wang DM, Song JG. Nat Commun; 2015 Sep 10; 6():8230. PubMed ID: 26354229 [Abstract] [Full Text] [Related]
5. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3. Zhou Q, Zheng X, Chen L, Xu B, Yang X, Jiang J, Wu C. Cell Physiol Biochem; 2016 Apr 10; 39(2):453-66. PubMed ID: 27383203 [Abstract] [Full Text] [Related]
6. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells. Zhang LL, Jiang XM, Huang MY, Feng ZL, Chen X, Wang Y, Li H, Li A, Lin LG, Lu JJ. Phytomedicine; 2019 Jan 10; 52():32-39. PubMed ID: 30599910 [Abstract] [Full Text] [Related]
9. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Phanish MK, Wahab NA, Colville-Nash P, Hendry BM, Dockrell ME. Biochem J; 2006 Jan 15; 393(Pt 2):601-7. PubMed ID: 16253118 [Abstract] [Full Text] [Related]
13. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells. Ko H, So Y, Jeon H, Jeong MH, Choi HK, Ryu SH, Lee SW, Yoon HG, Choi KC. Cancer Lett; 2013 Jul 10; 335(1):205-13. PubMed ID: 23419524 [Abstract] [Full Text] [Related]
14. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression. Ali A, Zhang P, Liangfang Y, Wenshe S, Wang H, Lin X, Dai Y, Feng XH, Moses R, Wang D, Li X, Xiao J. Cell Death Dis; 2015 Mar 12; 6(3):e1681. PubMed ID: 25766320 [Abstract] [Full Text] [Related]
16. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. Chung AC, Zhang H, Kong YZ, Tan JJ, Huang XR, Kopp JB, Lan HY. J Am Soc Nephrol; 2010 Feb 12; 21(2):249-60. PubMed ID: 19959709 [Abstract] [Full Text] [Related]
17. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C, Liu P, Wu H, Cui P, Li Y, Liu Y, Liu Z, Gou S. Oncotarget; 2016 Mar 22; 7(12):14912-24. PubMed ID: 26908446 [Abstract] [Full Text] [Related]
18. Exogenous hydrogen sulfide donor NaHS alleviates nickel-induced epithelial-mesenchymal transition and the migration of A549 cells by regulating TGF-β1/Smad2/Smad3 signaling. Ye M, Yu M, Yang D, Li J, Wang H, Chen F, Yu H, Shen T, Zhu Q, Zhou C. Ecotoxicol Environ Saf; 2020 Jun 01; 195():110464. PubMed ID: 32171946 [Abstract] [Full Text] [Related]
19. OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer. Li Y, Li L, Qin J, Wu J, Dai X, Xu J. Oncogene; 2021 Jan 01; 40(1):68-84. PubMed ID: 33051597 [Abstract] [Full Text] [Related]
20. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. Petersen M, Pardali E, van der Horst G, Cheung H, van den Hoogen C, van der Pluijm G, Ten Dijke P. Oncogene; 2010 Mar 04; 29(9):1351-61. PubMed ID: 20010874 [Abstract] [Full Text] [Related] Page: [Next] [New Search]